BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11919392)

  • 1. Chronic eosinophilic leukaemia presenting with erythroderma, mild eosinophilia and hyper-IgE: clinical, immunological and cytogenetic features and therapeutic approach. A case report.
    Granjo E; Lima M; Lopes JM; Dória S; Orfão A; Ying S; Barata LT; Miranda M; Cross NC; Bain BJ
    Acta Haematol; 2002; 107(2):108-12. PubMed ID: 11919392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hypereosinophilic dermatitis. An overlooked diagnosis?].
    Kemmler N; Peitsch WK; Glorer E; Goerdt S
    Hautarzt; 2005 Nov; 56(11):1060-7. PubMed ID: 16267687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. World Health Organization-defined eosinophilic disorders: 2014 update on diagnosis, risk stratification, and management.
    Gotlib J
    Am J Hematol; 2014 Mar; 89(3):325-37. PubMed ID: 24577808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case for diagnosis. Erythroderma as manifestation of hypereosinophilic syndrome.
    Merlotto MR; Cantadori LO; Sakabe D; Miot HA
    An Bras Dermatol; 2018 Jun; 93(3):451-453. PubMed ID: 29924226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypereosinophilia associated with dysplastic features and a constitutional translocation previously not described.
    Hermida G; Manjón R; Rodríguez-Salazar M; Calasanz MJ
    Haematologica; 2000 Sep; 85(9):997-8. PubMed ID: 10980647
    [No Abstract]   [Full Text] [Related]  

  • 6. [Eosinophilic ascites as a presenting symptom of the hypereosinophilic syndrome].
    Rimbrot S; Bennett M; Komorovski M; Levy Y
    Harefuah; 2001 Jun; 140(6):471-2, 567. PubMed ID: 11420842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytogenetic study on eosinophilia].
    Zhang Y; He Q; Huang XJ; Jiang H; Yang SM; Lu J; Qing YZ; Shi Y; Dang H; Qiu JY; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Jun; 15(3):454-7. PubMed ID: 17605843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete haematological and cytogenetic response to interferon alpha-2a of a myeloproliferative disorder with eosinophilia associated with a unique t(4;7) aberration.
    Schöffski P; Ganser A; Pascheberg U; Büsche G; Gaede B; Hertenstein B
    Ann Hematol; 2000 Feb; 79(2):95-8. PubMed ID: 10741923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 8p11 myeloproliferative syndrome preceded by t(8;9)(p11;q33), CEP110/FGFR1 fusion transcript: morphologic, molecular, and cytogenetic characterization of myeloid neoplasms associated with eosinophilia and FGFR1 abnormality.
    Park TS; Song J; Kim JS; Yang WI; Song S; Kim SJ; Suh B; Choi JR
    Cancer Genet Cytogenet; 2008 Mar; 181(2):93-9. PubMed ID: 18295660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypereosinophilia associated with increased serum levels of carcinoembryonic antigen.
    Iwata H; Tsuboi N; Ishii T; Hara Y; Okido I; Takahashi H; Kawamura T; Hosoya T
    Intern Med; 2008; 47(10):963-7. PubMed ID: 18480583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Eosinophilia--a challenging differential diagnosis].
    Seifert M; Gerth J; Gajda M; Pester F; Pfeifer R; Wolf G
    Med Klin (Munich); 2008 Aug; 103(8):591-7. PubMed ID: 18807233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic eosinophilic leukaemia (CEL): a distinct myeloproliferative disease.
    Weide R; Rieder H; Mehraein Y; Wolf M; Kaiser U; Seifart U; Görg C; Havemann K
    Br J Haematol; 1997 Jan; 96(1):117-23. PubMed ID: 9012697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Differential diagnosis of eosinophilia in combination with intoxication syndrome].
    Egorov IV; Kotina LN
    Klin Med (Mosk); 2004; 82(8):70-2. PubMed ID: 15468731
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypereosinophilic syndrome or chronic eosinophilic leukemia: report of a case with a lytic bone lesion.
    Juneja S; Stewart J; McKenzie A; Venter D; Januszewicz H
    Leukemia; 1997 May; 11(5):765-6. PubMed ID: 9180305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloproliferative hypereosinophilic syndrome presenting as cardiac failure and response to imatinib.
    Desai N; Morkhandikar S; Sahay R; Jijina F; Patil P
    Am J Ther; 2014; 21(2):e35-7. PubMed ID: 24603276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood and Bone Marrow Evaluation for Eosinophilia.
    Boyer DF
    Arch Pathol Lab Med; 2016 Oct; 140(10):1060-7. PubMed ID: 27684977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders with eosinophilia, treatment of hypereosinophilic syndrome].
    Borbényi Z
    Orv Hetil; 2005 May; 146(18 Suppl 1):911-6. PubMed ID: 15921304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Lymphocytic Variant of Hypereosinophilic Syndrome Presenting With Isolated Cutaneous Manifestations.
    Kamal Idrissi O; Hali F; El Fatoiki F; Chiheb S
    Cureus; 2022 Sep; 14(9):e29745. PubMed ID: 36340564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic myeloproliferative disorders: the role of tyrosine kinases in pathogenesis, diagnosis and therapy.
    Macdonald D; Cross NC
    Pathobiology; 2007; 74(2):81-8. PubMed ID: 17587879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does hypereosinophilic syndrome precede common B acute lymphoblastic leukaemia in childhood? A case report.
    Ayhan AC; Timur C; Ayhan Y; Cakır B; Erguven M
    Acta Haematol; 2012; 127(2):90-2. PubMed ID: 22156491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.